Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: A double-edged sword?

OncoImmunology

Volumn 2, Issue 7, 2013, Pages

  Blanc, Katarina Le ^a   Jitschin, Regina ^a,b   Mougiakakos, Dimitrios ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Allo HSCT; GvHD; GvT; IDO; MDSCs

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CANCER INFILTRATION; CLINICAL EFFECTIVENESS; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; INTERFERON PRODUCTION; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; MELANOMA; NATURAL KILLER CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL;

EID: 84886943722     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.25009     Document Type: Article

References (10)

1. Ferrara JL, Levine JE, Reddy P, Holler E. Graftversus- host disease. Lancet 2009; 373:1550-61; PMID:19282026; http://dx.doi.org/10.1016/S0140- 6736(09)60237-3
2. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
3. Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 2010; 185:2273-84; PMID:20644162; http://dx.doi.org/10.4049/jimmunol. 1000901
4. Mougiakakos D, Jitschin R, von Bahr L, Poschke I, Gary R, Sundberg B, et al. Immunosuppressive CD14+HLADRlow/ neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia 2013; 27:377-88; PMID:22828446; http:// dx.doi.org/10.1038/leu.2012.215
5. Poschke I, Mougiakakos D, Hansson J, Masucci GV, Kiessling R. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res 2010; 70:4335-45; PMID:20484028; http://dx.doi.org/10.1158/0008-5472.CAN-09-3767
6. Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011; 117:6532-41; PMID:21493801; http://dx.doi. org/10.1182/blood-2010-11-317321
7. Landfried K, Zhu W, Waldhier MC, Schulz U, Ammer J, Holler B, et al. Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine-2,3-dioxygenase. Blood 2011; 118:6971- 4; PMID:22039265; http://dx.doi.org/10.1182/blood- 2011-06-357814
8. Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R, et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010; 116:5738-47; PMID:20807889; http://dx.doi. org/10.1182/blood-2010-06-287839
9. Wang D, Yu Y, Haarberg K, Fu J, Kaosaard K, Nagaraj S, et al. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant 2013; 19:692-702; PMID:23376089; http://dx.doi.org/10.1016/j.bbmt.2013.01.008
10. Tacke RS, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR, et al. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 2012; 55:343-53; PMID:21953144; http://dx.doi. org/10.1002/hep.24700